TSHA · Taysha Gene Therapies, Inc. · Debt
Market Cap
$1.65B
Shares
325.83M
Debt Profile
Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.
Debt data is being processed. Please check back later.
Key facts
CIK
1806310
CUSIP
877619106
13F (30d)
111 filings
111 filers
Visit website
Investor relations